Back
ESC Premium Access

Effect of cardiovascular risk factors on left ventricular ejection fraction in HER2 positive breast cancer patients who were treated in adjuvant setting with trastuzumab

Session: Poster Session 3 - Chronic heart failure – Pathophysiology and mechanisms
Topic: Cardiotoxicity of Drugs and Other Therapies
Speaker: Professor M. Deljanin Ilic (Niska Banja, RS)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Professor Marina Deljanin Ilic

Institute of Cardiology Niska Banja, School of Medicine University of Nis, Niska Banja (Serbia)
0 follower

11 more presentations in this session

Cell growth, survival, and differentiation signal transduction pathways in advanced failing myocardium (gender dependent differences).

Speaker: Professor P. Leszek (Warsaw, PL)

Access
Abstract
Slides
Thumbnail

Accumulating evidence for deleterious effects of digoxin in heart failure and atrial fibrillation: an updated meta-analysis

Speaker: Associate Professor M. Vamos (Szeged, HU)

Access
Abstract
Slides
Thumbnail

Therapeutic validity and effectiveness of guideline-recommended medical therapy in acute heart failure patients on regular hemodialysis

Speaker: Doctor K. Mizobuchi (Tokyo, JP)

Access
Abstract
Thumbnail

Cardioprotective potential of an SGLT2 inhibitor against doxorubicin-induced heart failure

Speaker: Assistant Professor S. Cho (Seoul, KR)

Access
Abstract
Thumbnail

Sympathomimetic beta-1AR autoantibodies in patients after heart transplantation are associated with higher mitochondrial coupling efficiency

Speaker: Doctor J. Haschemi (Duesseldorf, DE)

Access
Abstract
Slides
Thumbnail

Access the full session

Poster Session 3 - Chronic heart failure – Pathophysiology and mechanisms

Speakers: Professor M. Deljanin Ilic, Professor P. Leszek, Associate Professor M. Vamos, Doctor K. Mizobuchi, Assistant Professor S. Cho...
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb